| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |